Ark appoints new CFO and secretary
This article was originally published in Clinica
Ark Therapeutics has promoted David Bowyer to chief financial officer and Edward Bliss to company secretary. Martyn Williams, who recently became CEO of the company, previously held both positions. Mr Bowyer joined Ark (London, UK) in 2004, and was promoted to group financial controller in 2008. Before this, he worked for Deloitte for four years. Dr Bliss, who also holds the position of general counsel, joined Ark in 2005. Previously, he worked for the US law firm Covington & Burling. Ark markets five devices including its Kerraboot dressing and Neuropad diagnostic, and is also developing several pharmaceuticals.